Towards the improvement of compliance: The significance of psycho-education and new antipsychotic drugs

被引:41
作者
Gaebel, W
机构
关键词
schizophrenia; neuroleptic treatment; relapse prevention; non-compliance; psycho-education; new antipsychotics;
D O I
10.1097/00004850-199702001-00006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Effective pharmacological, psychosocial and other kinds of treatment are now available for schizophrenia. Often, however, neither acute nor long-term treatment can be properly applied because of insufficient compliance by both patients and doctors. Patient noncompliance is as high as 50% under outpatient conditions; potential reasons may be either illness-related (e.g. lack of insight or idiosyncratic concepts of the illness or its treatment), drug-related (e.g. intolerable side effects) or related to inadequate treatment management (e.g. insufficient information or lack of environmental support). Non-compliance by doctors is partly due to limited adherence to treatment guidelines. To improve both patient and doctor compliance, the use of educational tools for professional health-care providers, patients and families should be generally enforced. New antipsychotics with a better risk-benefit profile with respect to clinical efficacy and side effects will probably help to overcome drug-related non-compliance.
引用
收藏
页码:S37 / S42
页数:6
相关论文
共 48 条
[1]  
[Anonymous], INNOVATIONS PSYCHOL
[2]   EARLY TREATMENT EVENTS AND PREDICTION OF RESPONSE TO NEUROLEPTICS IN SCHIZOPHRENIA [J].
AWAD, AG ;
HOGAN, TP .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1985, 9 (5-6) :585-588
[3]  
BABIKER IE, 1986, PSYCHIAT DEV, V4, P329
[4]   PSYCHOSOCIAL TREATMENT FOR SCHIZOPHRENIA [J].
BELLACK, AS ;
MUESER, KT .
SCHIZOPHRENIA BULLETIN, 1993, 19 (02) :317-336
[5]  
Churchill DN, 1985, MODERN MED CANADA, V40, P1068
[6]  
Clements K., 1992, INNOVATIONS PSYCHOL, P21
[7]   IMPORTANT ISSUES IN THE DRUG-TREATMENT OF SCHIZOPHRENIA [J].
DAVIS, JM ;
SCHAFFER, CB ;
KILLIAN, GA ;
KINARD, C ;
CHAN, C .
SCHIZOPHRENIA BULLETIN, 1980, 6 (01) :70-87
[8]   FAMILY MANAGEMENT IN THE PREVENTION OF EXACERBATIONS OF SCHIZOPHRENIA - A CONTROLLED-STUDY [J].
FALLOON, IRH ;
BOYD, JL ;
MCGILL, CW ;
RAZANI, J ;
MOSS, HB ;
GILDERMAN, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (24) :1437-1440
[9]  
FALLOON IRH, 1985, ARCH GEN PSYCHIAT, V42, P887
[10]   EARLY NEUROLEPTIC INTERVENTION IN SCHIZOPHRENIA - ARE PRODROMAL SYMPTOMS VALID PREDICTORS OF RELAPSE [J].
GAEBEL, W ;
FRICK, U ;
KOPCKE, W ;
LINDEN, M ;
MULLER, P ;
MULLERSPAHN, F ;
PIETZCKER, A ;
TEGELER, J .
BRITISH JOURNAL OF PSYCHIATRY, 1993, 163 :8-12